Proxima Research International Executive and Leadership Team

Oleksandr Khraban, the Chief Executive Officer at Proxima Research International, directs the overarching corporate strategy and long-term vision for the organization. By analyzing complex pharmaceutical market trends, the Chief Executive Officer identifies growth opportunities across international territories. This leadership role involves constant collaboration with the Board to ensure alignment between operational output and financial objectives. Oleksandr Khraban maintains a rigorous focus on scaling the company's data analytics capabilities to support pharmaceutical manufacturers in diverse global markets. Through the implementation of high-level governance frameworks, the Chief Executive Officer drives organizational efficiency and market competitiveness. The executive prioritizes the expansion of the company's footprint in emerging regions, ensuring that the firm remains a leader in pharmaceutical intelligence. By fostering a culture of innovation, the Chief Executive Officer secures the company's position as a vital partner for global healthcare stakeholders, ultimately enhancing the value delivered to clients worldwide.

Oleksii Bedun, the Group Chief Financial Officer at Proxima Research International, directs the financial planning, budgeting, and reporting processes for the entire organization. By monitoring cash flow and managing capital investments, the Group Chief Financial Officer ensures the company maintains a strong balance sheet to support its pharmaceutical research operations. This role involves conducting detailed financial analysis to guide executive decision-making and long-term strategic planning. Oleksii Bedun oversees the audit and compliance functions, ensuring that all financial activities adhere to international regulatory standards. By providing transparent financial insights to the Board, the Group Chief Financial Officer facilitates informed investment in new data technologies and market expansion. The executive collaborates with other leaders to optimize cost structures and improve overall profit margins. Through the management of fiscal risks, the Group Chief Financial Officer secures the company's financial health, enabling the firm to continue providing high-value intelligence to the global pharmaceutical industry.

Nataliya Tadeyeva, the Chief Operating Officer (Up To 600 Employees In 5 Countries) at Proxima Research International, manages the day-to-day execution of business processes across the company's multi-national footprint. By streamlining workflows and optimizing resource allocation, the Chief Operating Officer (Up To 600 Employees In 5 Countries) ensures that all departments operate with maximum efficiency. This role involves overseeing the delivery of pharmaceutical research services to ensure that quality standards remain high across all five operating countries. Nataliya Tadeyeva coordinates with regional managers to resolve operational bottlenecks and improve service consistency. By implementing standardized procedures, the Chief Operating Officer (Up To 600 Employees In 5 Countries) supports the company's ability to scale operations while maintaining profitability. The executive works closely with the finance and IT teams to integrate new technologies into existing operational frameworks. Through rigorous oversight of daily activities, the Chief Operating Officer (Up To 600 Employees In 5 Countries) ensures that the firm meets its commitments to pharmaceutical clients worldwide.

Artem Andrushchenko, the Chief Information Officer at Proxima Research International, architects the digital infrastructure required to process vast amounts of pharmaceutical data. Overseeing the development of proprietary software platforms, the Chief Information Officer ensures that all technical systems remain secure, scalable, and highly responsive to client needs. This role involves managing complex data integration projects that support the company's core business model of providing actionable market intelligence. Artem Andrushchenko directs the IT department in maintaining robust cybersecurity protocols to protect sensitive industry information across all operational regions. By leveraging advanced analytics and cloud-based solutions, the Chief Information Officer optimizes the speed and accuracy of data delivery to pharmaceutical partners. The executive collaborates closely with other C-suite leaders to align technological investments with the company's strategic goals. Through continuous system upgrades, the Chief Information Officer maintains the firm's technological edge in the competitive pharmaceutical manufacturing landscape.

Evgeniy Kunda, the Chief Revenue Officer at Proxima Research International, drives the company's commercial success by managing global sales initiatives and client acquisition strategies. By identifying key market segments within the pharmaceutical industry, the Chief Revenue Officer builds sustainable revenue streams through long-term partnerships. This leadership role involves overseeing the entire sales lifecycle, from initial lead generation to contract negotiation and account management. Evgeniy Kunda coordinates with the marketing and product teams to ensure that service offerings meet the evolving demands of pharmaceutical manufacturers. By analyzing regional market performance, the Chief Revenue Officer optimizes pricing models and sales tactics to maximize profitability. The executive maintains a focus on expanding the company's presence in key international markets, ensuring consistent growth in revenue. Through the implementation of data-backed sales methodologies, the Chief Revenue Officer secures the financial stability of the organization while fostering strong relationships with major industry players.

Anatolii Shapovalov, the Chief Human Resources Officer at Proxima Research International, directs the talent acquisition and organizational development strategies necessary to support a workforce of nearly 1,000 employees. By implementing comprehensive training programs, the Chief Human Resources Officer ensures that the staff possesses the specialized skills required to navigate the complex pharmaceutical industry. This role involves managing performance evaluation systems and fostering a corporate culture that prioritizes innovation and professional growth. Anatolii Shapovalov oversees the alignment of human capital with the company's strategic objectives across all five operating countries. By developing competitive compensation and benefits packages, the Chief Human Resources Officer attracts and retains top-tier talent in the data analytics and pharmaceutical sectors. The executive collaborates with department heads to address staffing needs and improve operational efficiency. Through the promotion of inclusive workplace policies, the Chief Human Resources Officer strengthens the organizational foundation, ensuring that the company remains a preferred employer in the global market.